VANCOMYCIN HYDROCHLORIDE (Page 5 of 5)
For Oral Administration
Oral vancomycin is used in treating antibiotic-associated pseudomembranous colitis caused by C. difficile and for staphylococcal enterocolitis. Vancomycin is not effective by the oral route for other types of infections. The usual adult total daily dosage is 500 mg to 2 g given in 3 or 4 divided doses for 7 to 10 days. The total daily dose in children is 40 mg/kg of body weight in 3 or 4 divided doses for 7 to 10 days. The total daily dosage should not exceed 2 g. The appropriate dose may be diluted in 1 oz of water and given to the patients to drink. Common flavoring syrups may be added to the solution to improve the taste for oral administration. The diluted solution may be administered via a nasogastric tube.
HOW SUPPLIED/STORAGE AND HANDLING
Vancomycin Hydrochloride for Injection USP is supplied as follows:
NDC | Vancomycin Hydrochloride for Injection USP | Package Size |
70436-020-82 | 500 mg Vial (equivalent to 500 mg vancomycin) | 10 vials per carton |
70436-021-82 | 1 g Vial (equivalent to 1 gram vancomycin) | 10 vials per carton |
Prior to reconstitution, store at 20° to 25°C (68° to 77°F) [See USP controlled room temperature].
ANIMAL PHARMACOLOGY
In animal studies, hypotension and bradycardia occurred in dogs receiving an intravenous infusion of vancomycin hydrochloride 25 mg/kg, at a concentration of 25 mg/mL and an infusion rate of 13.3 mL/min.
REFERENCES
1. Moellering RC, Krogstad DJ, Greenblatt DJ: Vancomycin therapy in patients with impaired renal function: A nomogram for dosage. Ann Inter Med 1981;94:343.
NORMOSOL®-M is a registered trademark of Abbott Hospital Products (Division of Abbott Laboratories).
ISOLYTE® E is a registered trademark of McGaw, Inc.
Manufactured by:
Hainan Poly Pharm. Co., Ltd., China
Guilinyang Economic Development Area, Haikou, Hainan Province, China 571127
Distributed by:
Slate Run Pharmaceuticals, LLC
Columbus, Ohio 43215
10000053/02
Revised: 05/2021
PRINCIPAL DISPLAY PANEL — 500 mg Vial Label
NDC 70436-020-82
PRINCIPAL DISPLAY PANEL – 1 g Vial Label
NDC 70436-021-82
VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride injection, powder, lyophilized, for solution | |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
|
VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride injection, powder, lyophilized, for solution | |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
|
Labeler — Slate Run Pharmaceuticals, LLC (039452765) |
Registrant — Hainan Poly Pharm. Co., Ltd. (654561638) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Hainan Poly Pharm. Co., Ltd. | 654561638 | manufacture (70436-021), manufacture (70436-020), analysis (70436-021), analysis (70436-020) |
Revised: 05/2021 Slate Run Pharmaceuticals, LLC
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.
https://medlibrary.org/lib/rx/meds/vancomycin-hydrochloride-25/page/5/